Candel Therapeutics
CADL
CADL
45 hedge funds and large institutions have $37M invested in Candel Therapeutics in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
6.96% more ownership
Funds ownership: 13.07% → 20.03% (+7%)
10% less call options, than puts
Call options by funds: $548K | Put options by funds: $612K
Holders
45
Holding in Top 10
2
Calls
$548K
Puts
$612K
Top Buyers
| 1 | +$4.81M | |
| 2 | +$2.76M | |
| 3 | +$2.37M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.72M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.56M |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$225K | |
| 3 | -$52.9K | |
| 4 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$47.1K |
| 5 |
TIA
Traphagen Investment Advisors
Oradell,
New Jersey
|
-$27.2K |